218-OR: Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study
Keyword(s):
1999 ◽
Vol 77
(1)
◽
pp. 140-143
◽
Keyword(s):
2003 ◽
Vol 3
(2)
◽
pp. 201-205
◽
Keyword(s):
1999 ◽
Vol 16
(3)
◽
pp. 228-232
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 34
(5)
◽
pp. 340-344
◽
2010 ◽
Vol 6
(5)
◽
pp. 274-284
◽